1.Clinical analysis of the gynecomastia.
Jin KIM ; Ing Gon KIM ; Ki Il UHM ; Hee Youn CHOI ; Jai Mann LEW ; Dai Sup KIM
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1991;18(6):1131-1137
No abstract available.
Gynecomastia*
;
Male
2.Bilateral Atypical Ductal Hyperplasia with Microcalcifications in a Patient with Gynecomastia.
Pedro VIDAL ; Juan Enrique BERNER ; Alejandra KLENNER ; Oscar TAPIA
Archives of Plastic Surgery 2016;43(3):299-301
No abstract available.
Gynecomastia*
;
Humans
;
Hyperplasia*
;
Male
3.A Case of Isoniazid Induced Gynecomastia.
Min Kyung LEE ; Dong Jib NA ; Ho Seok JEON ; Yang Deok LEE ; Yong Seon CHO ; Min Soo HAN ; Hee Jeong YOON
Tuberculosis and Respiratory Diseases 2009;66(1):33-36
No abstract available.
Gynecomastia
;
Isoniazid
;
Male
4.Unilateral Gynecomastia in a Tennis Player.
Sang Gue KANG ; Woo Jin SONG ; Chul Han KIM ; Ju Won KIM ; Min Sung TARK
Archives of Plastic Surgery 2012;39(6):675-678
No abstract available.
Gynecomastia
;
Male
;
Tennis
5.Gynecomastia in a Filipino adolescent male: A rare forewarning sign of fibrolamellar hepatocellular carcinoma
Leah Mae C. Besa ; Germana Emerita V. Gregorio
Acta Medica Philippina 2023;57(1):54-57
We present a 15-year-old male with a two-year history of gynecomastia and a four-month history of gradually enlarging abdomen and right flank pain. Examination revealed severe stunting with breast mass Tanner Stage 3, penile stage 2, and hepatosplenomegaly. Laboratory investigations showed normal blood counts, liver function tests, alpha-fetoprotein, and beta-human chorionic gonadotropin. The imaging findings demonstrated multiple confluent masses in the liver, histologically diagnosed as fibrolamellar hepatocellular carcinoma.
gynecomastia
;
fibrolamellar hepatocellular carcinoma
;
6.Two Cases of ReVersible Bilateral Painful Gynecomastia Induced by 1mg Oral Finasteride(Propecia(R)).
Beom Joon KIM ; Yu Jin KIM ; Byung In RO
Korean Journal of Dermatology 2003;41(2):232-234
Oral finasteride(Propecia(R)), 1mg/day, has been widely used as an effective treatment for male androgenetic alopecia since it had been approved by the Food and Drug Administration(FDA) of U.S. in December 1997. Gynecomastia has been one of the most common adverse effects in the patients who were taking 5mg of oral finasteride(Proscar(R)). Recently, several cases of unilateral or bilateral finasteride induced gynecomastia have also been reported in 1mg of oral finasteride(Propecia(r)). We report two cases of finasteride(Propecia(R)) induced painful bilateral gynecomastia, which are the first published documentations in Korea.
Alopecia
;
Documentation
;
Finasteride
;
Gynecomastia*
;
Humans
;
Korea
;
Male
7.Hyperkeratosis of Nipple and Areola in a Man with Gynecomastia.
Korean Journal of Dermatology 2002;40(8):991-994
Hyperkeratosis of nipple and areola (HNA) is a rare benign condition of unknown etiology characterized by hyperkeratosis, verrucous thickening with brownish discoloration of nipple and areola. The nevoid form is predominantly seen in females and there are a few reports of HNA in men. Gynecomastia is benign enlargement of the male breast due to proliferation of the glandular component and associated with various conditions. It typically develops when there is an increase in the ratio of estrogen to androgen. We present a case of bilateral nevoid hyperkeratosis of nipple and areola occurring in a man with gynecomastia.
Breast
;
Estrogens
;
Female
;
Gynecomastia*
;
Humans
;
Male
;
Nipples*
8.A Case of Macrogynecomastia Treated by Reduction Mammoplasty.
Hyeong Doo CHO ; Je Woo KIM ; Young Ah LEE ; Hae Sun YOON ; Jeh Hoon SHIN ; Phil Soo OH
Journal of Korean Society of Pediatric Endocrinology 1998;3(2):237-241
Gynecomastia is a proliferation of the glandular component of the male breast. Gynecomastia is the most common variant condition of the male breast and results from the effect of an altered estrogen-androgen balance on breast tissue or from the increased sensitivity of breast tissue to a normal estrogen level. We experienced a case of macrogynecomastia in a 16-year-old boy who had a normal male phenotype and was treated by reduction mammoplasty with breast tissue removal, which was effective and produced good cosmetic and psychologic results.
Adolescent
;
Breast
;
Estrogens
;
Female
;
Gynecomastia
;
Humans
;
Male
;
Mammaplasty*
;
Phenotype
9.Gynecomastia Treated with Tumescent Liposuction and the Pull-Through Technique.
Young Seok LEE ; Jong Keun SEO ; Tae Gwang KWON ; Hyun Soo SIM ; Sook Kyung LEE
Korean Journal of Dermatology 2011;49(8):748-752
Gynecomastia is the most common condition affecting the male breast due to enlargement of both ductal and stromal tissue. Growth of the male breast can be manifested at any age, but 40% of cases present in adolescent boys. The condition depends mainly on the balance between serum estrogens and androgens. Gynecomastia represents a source of embarrassment, and optimal correction is difficult to achieve. Numerous methods of gynecomastia repair are available. Our method is a combination of liposuction and the pull-through technique. The purpose of this treatment is to resect excess tissue and restore the normal chest contour with minimal scarring. We report a case of gynecomastia treated with a combination of tumescent liposuction and the pull-through technique.
Adolescent
;
Androgens
;
Breast
;
Cicatrix
;
Estrogens
;
Gynecomastia
;
Humans
;
Lipectomy
;
Male
;
Thorax
10.Idiopathic Unilateral Gynecomastia in an Adolescent Male: A Case Report.
Si Hyun PARK ; Jun Hyuk KIM ; Hwan Jun CHOI ; Young Man LEE ; Yo Ahn CHOI
Archives of Aesthetic Plastic Surgery 2017;23(2):101-103
Gynecomastia refers to persistent enlargement of the breast in males caused by enlargement of the breast bud and surrounding stroma. It typically occurs in newborns, during early adolescence, and in late adulthood. There are several pathological causes. If no pathological cause is evident, gynecomastia is considered idiopathic. The reported prevalence of unilateral gynecomastia is approximately 35% to 45%, but most previous reports have focused on distinctive pathologic causes. As such, few previous reports of idiopathic unilateral gynecomastia during early adolescence have been published. Herein, we report a case of idiopathic unilateral gynecomastia in an adolescent male.
Adolescent*
;
Breast
;
Gynecomastia*
;
Humans
;
Infant, Newborn
;
Male
;
Male*
;
Prevalence